Virtu Financial’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-34,276
| Closed | -$64K | – | 1893 |
|
|
2024
Q4 | $64K | Sell |
34,276
-9,112
| -21% | -$17K | ﹤0.01% | 1114 |
|
|
2024
Q3 | $44K | Buy |
+43,388
| New | +$44K | ﹤0.01% | 1034 |
|
|
2024
Q2 | – | Sell |
-157,516
| Closed | -$198K | – | 1764 |
|
|
2024
Q1 | $198K | Buy |
+157,516
| New | +$198K | 0.02% | 795 |
|
|
2023
Q4 | – | Sell |
-11,184
| Closed | -$19K | – | 1907 |
|
|
2023
Q3 | $19K | Sell |
11,184
-924
| -8% | -$1.57K | ﹤0.01% | 1024 |
|
|
2023
Q2 | $24K | Buy |
+12,108
| New | +$24K | ﹤0.01% | 1235 |
|
|
2022
Q3 | – | Sell |
-28,816
| Closed | -$31K | – | 2118 |
|
|
2022
Q2 | $31K | Buy |
28,816
+13,617
| +90% | +$14.6K | ﹤0.01% | 1245 |
|
|
2022
Q1 | $16K | Sell |
15,199
-3,172
| -17% | -$3.34K | ﹤0.01% | 1324 |
|
|
2021
Q4 | $15K | Buy |
+18,371
| New | +$15K | ﹤0.01% | 1541 |
|
|
2021
Q2 | – | Sell |
-27,744
| Closed | -$124K | – | 1951 |
|
|
2021
Q1 | $124K | Buy |
+27,744
| New | +$124K | 0.01% | 1247 |
|
|
2019
Q3 | – | Sell |
-1,948
| Closed | -$9K | – | 1725 |
|
|
2019
Q2 | $9K | Sell |
1,948
-5,869
| -75% | -$27.1K | ﹤0.01% | 1371 |
|
|
2019
Q1 | $34K | Sell |
7,817
-1,369
| -15% | -$5.95K | ﹤0.01% | 1239 |
|
|
2018
Q4 | $29K | Buy |
9,186
+2,823
| +44% | +$8.91K | ﹤0.01% | 1329 |
|
|
2018
Q3 | $46K | Buy |
6,363
+4,094
| +180% | +$29.6K | ﹤0.01% | 1304 |
|
|
2018
Q2 | $10K | Buy |
+2,269
| New | +$10K | ﹤0.01% | 1901 |
|
|
2018
Q1 | – | Sell |
-3,599
| Closed | -$24K | – | 2441 |
|
|
2017
Q4 | $24K | Buy |
3,599
+653
| +22% | +$4.36K | ﹤0.01% | 2194 |
|
|
2017
Q3 | $17K | Buy |
+2,946
| New | +$17K | ﹤0.01% | 2370 |
|